Human PSC-based Modeling of Pulmonary Fibrosis Identifies p300/CBP Inhibition as a Suppressor of Alveolar Transitional Cell State
To characterize the human ATCS differentiation in terms of the dynamics of p300 binding, we performed CUT&Tag analysis for p300 in FD-AOs treated with or without bleomycin (BLM).